Overlake Arthritis and Osteoporosis Center – COVID-19 Vaccine Response

To our dear patients,

We understand that there are questions you may have about the COVID-19 vaccines.

Currently, the Overlake Arthritis and Osteoporosis Center does not administer any of the approved COVID 19 vaccines.

We are currently recommending that all our patients get the COVID 19 vaccines. This is consistent with the message from the American College of Rheumatology (ACR).

We are providing a summary of our recommendations here per CDC and ACR guidelines:

  • The risk of the COVID-19 infection is higher than the risk of getting a vaccine.
  • There are many benefits of getting vaccinated for COVID-19 and doing so will help end the pandemic.
  • We still need to wear masks, practice physical distancing and wash our hands to prevent the spread of the coronavirus.


Per American College of Rheumatology (updated 08/04/2021) the following are the guidelines for timing considerations for the immunomodulatory therapy and vaccination:

  1. For patients on Methotrexate, hold methotrexate for one (1) week AFTER each of the mRNA vaccine doses (Moderna and Pfizer).
  2. We are recommending the Moderna or Pfizer and not the Johnson and Johnson (single dose) vaccine at this time.
  3. Hold JAK-Inhibitors such as Xeljanz, Rinvoq and Olumiant for one week after each vaccine dose.
  4. For patients using ORENCIA subcutaneous injections, hold Orencia injections both one week prior and one week after the FIRST COVID-19 vaccine dose ONLY; no interruption around the second and third vaccine dose.
  5. For patients on ORENCIA IV Infusion, get the 3rd dose of COVID 19 vaccine two-three (2-3) weeks after Orencia infusion.
  6. For patients on Rituxan, discuss with Dr Arinola Dada or Dr Kent Ta, the appropriate time of dosing Rituxan relative to the time of vaccination.
  7. For all other biologics, there are no specific recommendation as those biologics do not interfere with the response to the vaccine. However, our recommendation for our patients getting infusions is to get the vaccine one (1) week prior to next infusion.
  8. For those self-administering injection biologics, it is advisable to not get the vaccine on the same day as the injections.

Who is eligible for the third dose?

People who are 12 years of age or older, have a condition or are taking medications or treatments that moderately or severely weakens their immune system and has received either the first two doses of Pfizer or Moderna vaccines are eligible for third dose.

We strongly suggest our patients with autoimmune disease conditions to get their third dose of Covid-19 vaccine.

Is it safe to get a third dose?

The Food and Drug Administration (FDA), Centers for Disease Control and Prevention and independent experts have determined that the benefits of getting the third dose outweigh any known or potential risks.

What about the people who received the Johnson and Johnson vaccine?

At this time, an additional dose for patients who are immunocompromised and received the Johnson& Johnson COVID-19 vaccine is not authorized by the FDA. We will update this website as soon as additional information will be available.

Does the third dose need to be of the same vaccine brand as the first two doses?

Your third dose should be of the same vaccine brand as your first two doses, if possible. If you cannot get the same vaccine brand (Pfizer or Moderna), you can get the other brand (Pfizer or Moderna)

Where can I get my third dose?

Please check with your local pharmacies, hospitals and community health centers if they offer third dose of COVID-19 vaccines. If possible, look for a site that offers the same vaccine brand as your first two doses (Moderna or Pfizer).